Results 221 to 230 of about 1,011,076 (298)

Improving healthcare efficiency through long-term care insurance (LTCI): a super-SBM and DID analysis of 291 Chinese cities. [PDF]

Front Public Health
Jin T, Halili A.
europepmc   +1 more source

Did the COVID-19 pandemic increase the long-term care insurance certification rate in Japan? An interrupted time-series analysis. [PDF]

Geriatr Gerontol Int
Seino S, Hata T, Mori H, Shinkai S, Fujiwara Y, Kobayashi E.   +5 more
europepmc   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Long-term care insurance in China: Current challenges and recommendations. [PDF]

J Glob Health
Chen S, Li L, Jiao L, Gong S, Wang Z, Liu H, Geldsetzer P, Yang J, Barnighausen T, Wang C.   +9 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Shaping Long-term Care Insurance Intentions Among Chinese Adults Aged 50-70: Role of Information Interventions in Health Risks. [PDF]

Innov Aging
Liu J, Hao J, Maitland E, Nicholas S, Wang J, Leng A.   +5 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

The system effect and group benefit equity of long-term care insurance from the perspective of short-term policy pilot. [PDF]

Front Public Health
He W, Liu H.
europepmc   +1 more source